Spectrum Pharmaceuticals, Inc. (SPPI)
| Market Cap | 177.07M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -158.67M |
| Shares Out | 163.96M |
| EPS (ttm) | -1.06 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,601,000 |
| Open | 1.12 |
| Previous Close | 1.13 |
| Day's Range | 1.05 - 1.14 |
| 52-Week Range | 1.05 - 4.54 |
| Beta | 1.84 |
| Analysts | Buy |
| Price Target | 6.20 (+474.1%) |
| Earnings Date | Nov 10, 2021 |
About SPPI
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include ROLONTIS, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor for non-small cell lung cancer tumors with various mutations; and Anti-CD20-IFNa, an antibody-interferon fusion molecule directed against CD20 that is in Phase I development for the treatment of patients with...
Financial Performance
Financial StatementsAnalyst Forecast
According to 5 analysts, the average rating for SPPI stock is "Buy." The 12-month stock price forecast is 6.20, which is an increase of 474.07% from the latest price.
News
Spectrum Pharmaceuticals Announces Strategic Restructuring
HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals Announces Strategic Restructuring
Trending Penny Stocks to Watch in January 2022
Which penny stocks are you watching this month? The post Trending Penny Stocks to Watch in January 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Spectrum Pharmaceuticals Announces New Strategic Investment by Hanmi Pharmaceutical
HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals Announces New Strategic Investment by Hanmi Pharmaceutical
Do Options Traders Know Something About Spectrum Pharmaceuticals (SPPI) Stock We Don't?
Investors need to pay close attention to Spectrum Pharmaceuticals (SPPI) stock based on the movements in the options market lately.
Down 38% in 4 Weeks, Here's Why You Should You Buy the Dip in Spectrum Pharma (SPPI)
The heavy selling pressure might have exhausted for Spectrum Pharma (SPPI) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analy...
Spectrum Pharmaceuticals Submits New Drug Application for Poziotinib
HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals Submits New Drug Application for Poziotinib
4 Top Penny Stocks To Buy For Under $5
Top penny stocks traders decided to buy today but are they worth the risk? The post 4 Top Penny Stocks To Buy For Under $5 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStock...
Spectrum Pharmaceuticals Announces Changes to Management Team and Board of Directors
HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals Announces Changes to Management Team and Board of Directors
Spectrum Pharmaceuticals to Participate in JMP Securities Hematology and Oncology Summit
HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals to Participate in JMP Securities Hematology and Oncology Summit
Spectrum Pharmaceuticals to Participate in 2021 Jefferies London Healthcare Conference
HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals to Participate in 2021 Jefferies London Healthcare Conference
Spectrum Pharmaceuticals Reports Third Quarter 2021 Financial Results and Corporate Update
HENDERSON, Nev.--(BUSINESS WIRE)---- $SPPI #earnings--Spectrum Pharmaceuticals Reports Third Quarter 2021 Financial Results and Corporate Update
Spectrum Pharmaceuticals to Report Third Quarter 2021 Financial Results and Provide Corporate Update
HENDERSON, Nev.--(BUSINESS WIRE)---- $SPPI--Spectrum Pharmaceuticals to Report Third Quarter 2021 Financial Results and Provide Corporate Update
SHAREHOLDER ALERT: Robbins LLP Investigates Spectrum Pharmaceuticals, Inc. (SPPI) for Misleading Shareholders
SAN DIEGO--(BUSINESS WIRE)---- $SPPI #FDA--Spectrum Pharmaceuticals, Inc. (SPPI) Accused of Materially Misrepresenting the Likelihood ROLONTIS would be approved by the FDA
SPPI LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Spectrum Pharmaceu...
New York, New York--(Newsfile Corp. - November 1, 2021) - The Law Offices of Vincent Wong announce that a class action lawsuit has commenced in the on behalf of investors who purchased Spectrum Pharmace...
SPPI ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of November 1, 2021 in the Class Action Filed on B...
New York, New York--(Newsfile Corp. - November 1, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Spectrum Pharmaceuticals, Inc. (NASDAQ: ...
CLASS ACTION UPDATE for SPPI, APPH and HYZN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Sh...
NEW YORK, NY / ACCESSWIRE / November 1, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholder...
Final Hours to Participate in Spectrum Pharmaceuticals, Inc. (SPPI) Class Action - Bronstein, Gewirtz & Grossman, LLC
New York, New York--(Newsfile Corp. - November 1, 2021) - Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Spectrum Pharmaceuticals, Inc. ("Spectr...
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Spectrum Pharmaceuticals, Inc. of a Class Action La...
New York, New York--(Newsfile Corp. - November 1, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of S...
SPPI Final Deadline Today: Rosen, National Trial Lawyers, Encourages Spectrum Pharmaceuticals, Inc. Investors with Lo...
New York, New York--(Newsfile Corp. - November 1, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) be...
SHAREHOLDER ALERT: SPPI SAM WDH: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
NEW YORK, NY / ACCESSWIRE / October 31, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a ...
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Spectrum Pharmaceutical...
New York, New York--(Newsfile Corp. - October 29, 2021) - Pomerantz LLP announces that a class action lawsuit has been filed against Spectrum Pharmaceuticals, Inc ("Spectrum" or the "Company") (NASDAQ:...
MONDAY DEADLINE REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Spectrum Pharmaceut...
Los Angeles, California--(Newsfile Corp. - October 29, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Spectrum Pharmaceu...
CLASS ACTION UPDATE for SPPI, INNV and ZEV: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Sha...
NEW YORK, NY / ACCESSWIRE / October 29, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholder...
Final Days to Participate in Spectrum Pharmaceuticals, Inc. (SPPI) Class Action - Bronstein, Gewirtz & Grossman, LLC
NEW YORK--(BUSINESS WIRE)--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Spectrum Pharmaceuticals, Inc. ("Spectrum” or the "Company") (NASDAQ: ...